The biochemistry of peroxisomal β-oxidation in the yeast Saccharomyces cerevisiae

…, AM Mursula, H Rottensteiner… - FEMS microbiology …, 2003 - academic.oup.com
Peroxisomal fatty acid degradation in the yeast Saccharomyces cerevisiae requires an
array of β-oxidation enzyme activities as well as a set of auxiliary activities to provide the β-…

[HTML][HTML] The biochemistry of oleate induction: transcriptional upregulation and peroxisome proliferation

A Gurvitz, H Rottensteiner - Biochimica et Biophysica Acta (BBA)-Molecular …, 2006 - Elsevier
Unicellular organisms such as yeast constantly monitor their environment and respond to
nutritional cues. Rapid adaptation to ambient changes may include modification and …

[HTML][HTML] The ins and outs of peroxisomes: co-ordination of membrane transport and peroxisomal metabolism

H Rottensteiner, FL Theodoulou - … et Biophysica Acta (BBA)-Molecular Cell …, 2006 - Elsevier
Peroxisomes perform a range of metabolic functions which require the movement of
substrates, co-substrates, cofactors and metabolites across the peroxisomal membrane. In this …

Peroxisomal membrane proteins contain common Pex19p-binding sites that are an integral part of their targeting signals

H Rottensteiner, A Kramer, S Lorenzen… - Molecular biology of …, 2004 - Am Soc Cell Biol
Targeting of peroxisomal membrane proteins (PMPs) is a multistep process that requires
not only recognition of PMPs in the cytosol but also their insertion into the peroxisomal …

[HTML][HTML] Identification and functional reconstitution of the yeast peroxisomal adenine nucleotide transporter

L Palmieri, H Rottensteiner, W Girzalsky… - The EMBO …, 2001 - embopress.org
The requirement for small molecule transport systems across the peroxisomal membrane
has previously been postulated, but not directly proven. Here we report the identification and …

ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice

…, A Vandenbulcke, H Rottensteiner… - Blood, The Journal …, 2016 - ashpublications.org
Rapid vascular recanalization forms the basis for successful treatment of cerebral ischemia.
Currently, tissue plasminogen activator (t-PA) is the only approved thrombolytic drug for …

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression

…, BM Reipert, H Rottensteiner… - Blood, The Journal …, 2021 - ashpublications.org
Gene therapy has the potential to maintain therapeutic blood clotting factor IX (FIX) levels in
patients with hemophilia B by delivering a functional human F9 gene into liver cells. This …

Low ADAMTS13 activity is associated with an increased risk of ischemic stroke

…, A Hofman, PL Turecek, H Rottensteiner… - Blood, The Journal …, 2015 - ashpublications.org
ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin motif repeats 13)
has antithrombotic properties because it cleaves von Willebrand factor (VWF) in smaller, less …

BAX 855, a PEGylated rFVIII product with prolonged half-life

…, EM Muchitsch, M Purtscher, H Rottensteiner… - …, 2012 - thieme-connect.com
A longer acting recombinant FVIII is expected to serve patients’ demand for a more convenient
prophylactic therapy. We have developed BAX 855, a PEGylated form of Baxter’s rFVIII …

Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice

…, A Schiviz, B Dietrich, H Rottensteiner… - Blood, The Journal …, 2012 - ashpublications.org
Coronary heart disease is a major cause of death in the western world. Although essential
for successful recovery, reperfusion of ischemic myocardium is inevitably associated with …